🇺🇸 FDA
Patent

US 9694002

Substituted benzamides and methods of use thereof

granted A61KA61K31/337A61K31/397

Quick answer

US patent 9694002 (Substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/337, A61K31/397, A61K31/4015, A61K31/415